Veralipride

Drugbox
IUPAC_name = 2,3-Dimethoxy-"N"- [(1-prop-2-enylpyrrolidin-2-yl)methyl] -5-sulfamoylbenzamide


CAS_number =
CAS_supplemental =
ATC_prefix =
ATC_suffix =
ATC_supplemental =
PubChem = 47979
DrugBank =
chemical_formula =
C=17 | H=25 | N=3 | O=5 | S=1
molecular_weight = 383.4625 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status = withdrawn
routes_of_administration = Oral

Veralipride (INN; brand names Agreal and Agradil) is a benzamide neuroleptic medicine indicated in the treatment of vasomotor symptoms associated with the menopause. It was first authorised for use in 1979. Veralipride has never gained approval in the United States.

On September 2006, it was withdrawn from the Spanish market. As a result, the European Commission referred the matter to the European Medicines Agency (EMA).

On July 2007, the EMA recommended the withdrawal of marketing authorisations for veralipride. [ [http://www.emea.europa.eu/pdfs/human/referral/agreal/Veralipride-H-A-31-788-en.pdf OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF MEDICINAL PRODUCTS CONTAINING VERALIPRIDE (from the EMEA website)] ]

References